ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹790 Cr | ₹731 Cr | ₹711 Cr | ₹688 Cr | ₹656 Cr |
What is the latest Total Non-Current Assets ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹790 Cr |
| Mar2025 | ₹731 Cr |
| Mar2024 | ₹711 Cr |
| Mar2023 | ₹688 Cr |
| Mar2022 | ₹656 Cr |
How is Total Non-Current Assets of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹790 Cr | 8.07 | |
| Mar2025 | ₹731 Cr | 2.79 | |
| Mar2024 | ₹711 Cr | 3.35 | |
| Mar2023 | ₹688 Cr | 4.98 | |
| Mar2022 | ₹656 Cr | - | |
Compare Total Non-Current Assets of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,073.3 Cr | -5.9% | -6.9% | -14.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -5.9% |
-6.9% |
-14.2% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses